鈴木 重明

Medicine & Life Sciences

1. 3-hydroxy-3-methylglutaryl-coenzyme A 12%
2. 4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy)pyrimidine hydrochloride 7%
3. Adrenal Cortex Hormones 5%
4. Amino Acyl-tRNA Synthetases 5%
5. Anti-Idiotypic Antibodies 17%
6. Antibodies 22%
7. Antisynthetase syndrome 5%
8. Autoantibodies 27%
9. Blepharoptosis 7%
10. Brain 6%
11. Brain Ischemia 19%
12. Calcineurin Inhibitors 6%
13. Cholinergic Receptors 10%
14. Connectin 9%
15. Creatine Kinase 5%
16. Cyclic AMP Response Element-Binding Protein 11%
17. Dermatomyositis 9%
18. eculizumab 8%
19. Hematopoietic Stem Cell Transplantation 5%
20. Human Herpesvirus 6 5%
21. Immunoprecipitation 6%
22. Inclusion Body Myositis 5%
23. Infarction 5%
24. Interleukin-6 7%
25. Ischemia 5%
26. Japan 12%
27. Limbic Encephalitis 6%
28. Middle Cerebral Artery Infarction 7%
29. Muscle Weakness 18%
30. Muscles 12%
31. Muscular Diseases 34%
32. Myasthenia Gravis 100%
33. Myelitis 5%
34. Myocarditis 8%
35. Myositis 45%
36. Neurons 5%
37. Nivolumab 8%
38. Oligodendrocyte Precursor Cells 6%
39. Oxidoreductases 11%
40. Phosphorylation 8%
41. Prednisolone 10%
42. Quality of Life 5%
43. Serum 6%
44. Signal Recognition Particle 23%
45. Skeletal Muscle 5%
46. T-Lymphocytes 5%
47. Therapeutics 8%
48. Thymectomy 5%
49. Thymoma 21%
50. Voltage-Gated Potassium Channels 5%